Scholarlink

Purpose <p>In light of previous studies eliminating the involvement of gene-mediated mechanisms in developing tedizolid resistance, our study elucidates the ability of mutation-mediated mechanisms to confer oxazolidinones cross-resistance in methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). With further investigation of the identified mutations and their relation to tedizolid resistance. Additionally, the involvement of <i>rpoB</i> mutations in acquiring resistance to tedizolid was also investigated.</p> Methods <p>Five <i>cfr-</i>negative, methicillin-resistant <i>Staphylococcus aureus</i> clinical isolates were subjected to in vitro selection to develop linezolid-resistant mutants. The resultant mutants were tested for acquiring tedizolid cross-resistance, whole genome sequencing was performed twice, followed by variant calling and annotation. Detected mutations were analyzed for their relatedness to the developed resistance.</p> Results <p>Mutations considered relevant to tedizolid resistance were detected in <i>rpoB</i> gene encoding β-subunit of the RNA polymerase enzyme and <i>rplC</i> gene encoding the 50S ribosomal protein L3. Additionally, mutations in <i>mepB</i> gene, part of the <i>mepRAB</i> operon were detected and believed to contribute to acquiring linezolid resistance.</p> Conclusion <p>To the best of our knowledge, our findings are the first to report the 50S ribosomal protein L3 mutation Gly152Asp to solely confer cross-resistance to both linezolid and tedizolid oxazolidinones. In addition, we report the emergence of cross-resistance between oxazolidinone antibiotics and rifampin through a single amino-acid substitution occurring within the Rifampin Resistance Determining Region (RRDR). Furthermore, <i>mepB</i> mutations reported in our results support a theory implying a second MepR-independent mechanism regulating the <i>mepRAB</i> operon, and are believed to be responsible for the acquired linezolid resistance in our study.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of genetic mutations conferring tedizolid resistance in MRSA mutants

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月13日

查看全文
  • Nesma B. Goda,
  • Amira M. El-Ganiny,
  • Tharwat R. El-khamissy,
  • Fares Z. Najar,
  • Ashraf A. Kadry

摘要

Purpose

In light of previous studies eliminating the involvement of gene-mediated mechanisms in developing tedizolid resistance, our study elucidates the ability of mutation-mediated mechanisms to confer oxazolidinones cross-resistance in methicillin-resistant Staphylococcus aureus (MRSA). With further investigation of the identified mutations and their relation to tedizolid resistance. Additionally, the involvement of rpoB mutations in acquiring resistance to tedizolid was also investigated.

Methods

Five cfr-negative, methicillin-resistant Staphylococcus aureus clinical isolates were subjected to in vitro selection to develop linezolid-resistant mutants. The resultant mutants were tested for acquiring tedizolid cross-resistance, whole genome sequencing was performed twice, followed by variant calling and annotation. Detected mutations were analyzed for their relatedness to the developed resistance.

Results

Mutations considered relevant to tedizolid resistance were detected in rpoB gene encoding β-subunit of the RNA polymerase enzyme and rplC gene encoding the 50S ribosomal protein L3. Additionally, mutations in mepB gene, part of the mepRAB operon were detected and believed to contribute to acquiring linezolid resistance.

Conclusion

To the best of our knowledge, our findings are the first to report the 50S ribosomal protein L3 mutation Gly152Asp to solely confer cross-resistance to both linezolid and tedizolid oxazolidinones. In addition, we report the emergence of cross-resistance between oxazolidinone antibiotics and rifampin through a single amino-acid substitution occurring within the Rifampin Resistance Determining Region (RRDR). Furthermore, mepB mutations reported in our results support a theory implying a second MepR-independent mechanism regulating the mepRAB operon, and are believed to be responsible for the acquired linezolid resistance in our study.